Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)

ClinicalTrials.gov ID: NCT04855721

Public ClinicalTrials.gov record NCT04855721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 6, 2026, 2:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Double-blind, Double-dummy, Placebo Controlled, Randomized Study to Evaluate the Efficacy and Safety of AUR101 in Patients With Moderate-to-Severe Psoriasis (INDUS-3)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase II, Multicenter, Double-blind, Double-dummy, Placebo controlled, Randomized Study to Evaluate the Efficacy and Safety of AUR101 in patients with Moderate-to-Severe Psoriasis (INDUS-3)

Study identification

NCT ID
NCT04855721
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
141 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 4, 2021 (Actual)
Primary completion
Nov 30, 2022 (Actual)
Completion
Dec 10, 2022 (Actual)
Last update posted
Dec 13, 2022

2021 – 2022

United States locations

U.S. sites
25
U.S. states
9
U.S. cities
22
Facility City State ZIP Site status
Johnson Dermatology Fort Smith Arkansas 72916 —
Northwest AR Clinical Trials Center Rogers Arkansas 72758 —
First OC Dermatology Fountain Valley California 92708 —
Dermatology Research Associates Los Angeles California 90045 —
University Clinical Trials, Inc. San Diego California 92123 —
Clinical Science Institute Santa Monica California 90404 —
Unison Clinical Trials Sherman Oaks California 91403 —
Moore Clinical Research, Inc. Brandon Florida 33511 —
Skin Research Institute Coral Gables Florida 33146 —
Accel Research Sites - Deland CRU DeLand Florida 32720 —
FXM Clinical Research Fort Lauderdale Fort Lauderdale Florida 33308 —
Direct Helpers Research Center Hialeah Florida 33012 —
Abys New Generation Research Inc. Hialeah Florida 33016 —
FXM Clinical Research Miami LLC Miami Florida 33175 —
Floridian Reserach Miami Florida 33179 —
FXM Clinical Research Miramar LLC Miramar Florida 33027 —
Lenus Research & Medical Group, LLC Sweetwater Florida 33172 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250 —
Great Lakes Research Group, Inc Bay City Michigan 48706 —
Medisearch Clinical Trials Saint Joseph Missouri 64506 —
The Dermatology Specialists New York New York 10012 —
Sadick Research Group New York New York 10075 —
Paddington Testing Co, Inc Philadelphia Pennsylvania 19103 —
Dermatology Treatment & Research Center Dallas Texas 75230 —
Center for Clinical Studies Ltd., LLP. Webster Texas 77598 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04855721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2022 · Synced Oct 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04855721 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →